BU-NOT-SET

CONTACT US
Optimising a prolonged release fixed dose combination product
  • Drug product
pills
Case study
Ensuring stability excellence for global consumer and OTC products
  • Analytical chemistry
  • Drug product
Woman and computer
Webinar
The impact of the COVID-19 pandemic on global pharmaceutical growth
  • Industry trends
Eyes
Insight
COVID-19: a year of unprecedented change
  • Industry trends
Eyes
Insight
Oral solids: market and technology trends
  • Drug product
Eyes
Insight
Oral modified release
  • Drug product
Granules
Fact sheet
Semi-solids an overview of current regulatory requirement
  • Drug product
Tube cream
Fact sheet
API relocation strategies for CDMO’s
  • Drug substance
Eyes
Insight
Clinical trial material
  • Drug product
  • Manufacturing
hand scooping pills
Fact sheet
White paper
  • Biologics
Cell and virus banking in OV development and manufacturing
Insight
  • Biologics
Overcoming technical transfer challenges in virotherapy manufacturing
eBook
  • Biologics
Flexibility in gene therapy: Adapting to the unique gene therapy demands
Webinar
  • Biologics
Webinar: An optimised Plasmid DNA platform
Insight
  • Drug substance
  • Industry trends
The future of oral solid dose formulations
Insight
  • Industry trends
Trends and challenges to impact the OSD space in 2024 and beyond
Insight
  • Sustainability
Shaping pharma's carbon-reduced future
Insight
  • Sustainability
Focus on sustainability: Saving water in Bengaluru
Insight
  • Drug product
  • Drug substance
Safe handling of highly potent active pharmaceutical ingredients